Alliance A212102 / MCED Biobank — Blinded Reference Set for Multicancer Early Detection Blood Tests

Observational · Solid Tumors

Population

Individuals with newly diagnosed cancer and cancer-free controls.

Primary Endpoint

Establishment of a blinded biospecimen reference set for MCED test evaluation

Rationale

Multi-cancer early detection blood tests require rigorously curated, blinded specimen sets to validate performance before implementation into healthcare.

What It Could Change

A robust reference set would enable standardized validation and eventual clinical implementation of MCED blood tests.